abstract |
A compound of the formulan n wherein: n X¹ is halo; n X² is hydrogen, halo, or CF₃; n A is C₂-C₇ alkyl; C₂-C₇ alkenyl; C₄-C₈ cycloalkyl; phenyl-substituted C₁-C₄ alkyl; phenyl-substituted C₂-C₄ alkenyl; or RZR¹ where R is phenyl or C₁-C₃ alkyl, R¹ is (CH₂) n where n is 1-3, and Z is oxygen or sulfur; n and pharmaceutically acceptable salts thereof, for the manufacture of a medicament for the treatment of susceptible neoplasms. |